Pegylated interferon induced myasthenia crisis - A case report

Journal of Clinical Neuromuscular Disease

Volumn 14, Issue 3, 2013, Pages 123-125

  Congeni, Jonathan P ^a   Kirkpatrick, Robert B ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

hepatitis C; interferon; myasthenia gravis

Indexed keywords

PEGINTERFERON; PYRIDOSTIGMINE; RIBAVIRIN; TELAPREVIR;

ADULT; CASE REPORT; DIABETES MELLITUS; DIPLOPIA; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; HEPATITIS C; HUMAN; LIVER DISEASE; MALE; MYASTHENIA GRAVIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTOSIS; REVIEW; TREATMENT DURATION;

HEPATITIS C; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 84875473101     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e318285257f     Document Type: Review

References (9)

1. Bektas M, Bektas H, Goren D, et al: Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. Digestion. 2007;75:208-209.
2. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25:283-291.
3. Ronnblom LE, Alm GV, Obert K, et al. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Int Med. 1991;115:178-183.
4. Niazi M, Azhar A, Tufail K, et al. Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: a case report. World J Hepatol. 2010;2:162-166.
5. Kiani V, Kelly T, Jensen D, et al. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2A therapy for chronic hepatitis C virus infection. World J Gastroenterol. 2008;14: 318-321.
6. Venezia G, Licata A, Di Marco V, et al. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Dig Liver Dis. 2005;37:882-885.
7. Kang H, Park M, Hwang J, et al. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. Korean J Hepatol. 2009;15:209-215.
8. Shiga K, Tanaka E, Isayama R, et al. Chronic inflammatory demyelinating polyneuropathy due to the administration of pegylated interferon alpha-2b: a neuropathology case report. Intern Med. 2012;51:217-221.
9. Piccolo G, Franciotta D, Versino M, et al. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment. J Neurol Neurosurg Psychiatry. 1996;60:348.